13-Feb-2026
Market Chameleon (Tue, 13-Jan 2:51 AM ET)
/C O R R E C T I O N -- Armata Pharmaceuticals, Inc./
PRNewswire (Tue, 13-Jan 7:42 AM ET)
PRNewswire (Tue, 13-Jan 7:00 AM ET)
PRNewswire (Tue, 18-Nov 7:00 AM ET)
Market Chameleon (Thu, 23-Oct 3:07 AM ET)
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
Armata Pharmaceuticals trades on the AMEX stock market under the symbol ARMP.
As of February 13, 2026, ARMP stock price declined to $8.15 with 25,299 million shares trading.
ARMP has a beta of 0.48, meaning it tends to be less sensitive to market movements. ARMP has a correlation of 0.01 to the broad based SPY ETF.
ARMP has a market cap of $296.09 million. This is considered a Small Cap stock.
Last quarter Armata Pharmaceuticals reported $1 million in Revenue and -$.74 earnings per share. This fell short of revenue expectation by $-221,000 and missed earnings estimates by -$.32.
In the last 3 years, ARMP traded as high as $16.34 and as low as $.90.
The top ETF exchange traded funds that ARMP belongs to (by Net Assets): VTI, VXF, IWC.
ARMP has outperformed the market in the last year with a price return of +309.5% while the SPY ETF gained +13.0%. ARMP has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +27.7% and +21.6%, respectively, while the SPY returned +1.7% and -1.5%, respectively.
ARMP support price is $7.62 and resistance is $8.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARMP shares will trade within this expected range on the day.